Multiplex Assay Kit for Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay)

FOX-P3; AIID; DIETER; IPEX; JM2; PIDX; XPID; SCURFIN; Forkhead Box Protein P3; Immune Dysregulation,Polyendocrinopathy,Enteropathy,X-Linked

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 95-103 99
EDTA plasma(n=5) 89-97 93
heparin plasma(n=5) 88-97 92
sodium citrate plasma(n=5) 91-105 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-101% 85-92% 97-104% 98-105%
EDTA plasma(n=5) 81-91% 79-101% 93-101% 95-105%
heparin plasma(n=5) 81-89% 82-91% 86-105% 91-99%
sodium citrate plasma(n=5) 80-101% 89-96% 80-91% 82-90%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FOXP3) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Basic and Clinical Physiology and Pharmacology Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes Pubmed: 23612652
The Journal of Rheumatol Genetic Polymorphisms of Foxp3 in Patients with Rheumatoid Arthritis Pubmed:25448791#
网页进不去,NCBI上搜不到 Increasing Foxp3, IgG4 and improvement quality of life after immunotherapy treatment in allergic rhinitis patients article:30785
Journal of Autoimmune Disorders The Role of T-Regulatory Expression in Autoimmune Thyroid Disease and its Association with Thyroid _x005f_x0004_Antibody the-role-of-tregulatory-expression-in-autoimmune-t
Inflammation Research gene polymorphisms and its protein level in patients with rheumatoid arthritis: a case–control study Pubmed:29411043
PLoS One Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice Pubmed: 30307955
Evidence-Based Complementary and Alternative Medicine Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression Doi: 10.1155/2018/2428546
PLoS One Alteration of oxidative-stress and related marker levels in mouse colonic tissues and fecal microbiota structures with chronic ethanol administration ¡­ 33577585
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB877Hu01 Recombinant Forkhead Box P3 (FOXP3) Positive Control; Immunogen; SDS-PAGE; WB.
RPB877Hu02 Recombinant Forkhead Box P3 (FOXP3) Positive Control; Immunogen; SDS-PAGE; WB.
PAB877Hu01 Polyclonal Antibody to Forkhead Box P3 (FOXP3) WB; IHC; ICC; IP.
MAB877Hu22 Monoclonal Antibody to Forkhead Box P3 (FOXP3) WB; IHC; ICC; IP.
MAB877Hu21 Monoclonal Antibody to Forkhead Box P3 (FOXP3) WB; IHC; ICC; IP.
SEB877Hu ELISA Kit for Forkhead Box P3 (FOXP3) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB877Hu Multiplex Assay Kit for Forkhead Box P3 (FOXP3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB877Hu01 ELISA Kit DIY Materials for Forkhead Box P3 (FOXP3) Main materials for "Do It (ELISA Kit) Yourself".